Studies with the KRas4B‐derived CaaX‐1 peptide (GLRKRLRKFRNK‐SKTKCVIM) revealed that this peptide altered downstream signaling of Ras proteins in KRas mutant pancreatic cancer cells. This evidence concerns the gene KRAS and familial pancreatic carcinoma.